Oncternal Therapeutics, Inc.

NasdaqCM:ONCT Stock Report

Market Cap: US$23.6m

Oncternal Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:ONCT Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
08 Apr 24BuyUS$27,655Robert WillsIndividual3,086US$8.96
28 Mar 24BuyUS$58,602Robert WillsIndividual6,914US$8.48
23 Feb 24BuyUS$6,455David HaleIndividual714US$9.04
23 Feb 24BuyUS$2,405Hale BioPharma Ventures LLCCompany266US$9.04
23 Feb 24SellUS$8,859Robert WillsIndividual980US$9.04
14 Jun 23BuyUS$9,824Gunnar KaufmannIndividual1,400US$7.19

Insider Trading Volume

Insider Buying: ONCT insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of ONCT?
Owner TypeNumber of SharesOwnership Percentage
Private Companies30,8381.15%
Individual Insiders72,4582.69%
Public Companies177,2226.59%
Institutions491,13318.3%
General Public1,917,58271.3%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 27.32% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
6.59%
Shanghai Pharmaceuticals Holding Co., Ltd
177,222US$1.6m0%no data
5.32%
The Vanguard Group, Inc.
143,045US$1.3m0%no data
3.82%
Millennium Management LLC
102,795US$901.0k24.8%no data
1.46%
BlackRock, Inc.
39,284US$344.3k0%no data
1.22%
James Breitmeyer
32,787US$287.4k14%no data
1.2%
Charles Schwab Investment Management, Inc.
32,249US$282.7k1,900%no data
1.1%
Hale BioPharma Ventures LLC
29,673US$260.1k0.9%no data
0.96%
Dimensional Fund Advisors LP
25,892US$226.9k0%no data
0.92%
Richmond Brothers, Inc.
24,702US$216.5k0%0.4%
0.88%
Geode Capital Management, LLC
23,797US$208.6k0%no data
0.61%
Renaissance Technologies LLC
16,360US$143.4k4.44%no data
0.37%
Robert Wills
10,000US$87.6k822%no data
0.32%
LPL Financial Corporation, Asset Management Arm
8,572US$75.1k0%no data
0.3%
State Street Global Advisors, Inc.
8,070US$70.7k0%no data
0.28%
Tareno International Asset Managers
7,398US$64.8k0%0.03%
0.27%
Richard Vincent
7,364US$64.5k15.9%no data
0.27%
IEQ Capital, LLC
7,221US$63.3k0%no data
0.26%
BIT Capital GmbH
7,000US$61.4k0%0.08%
0.24%
Salim Yazji
6,432US$56.4k38.6%no data
0.17%
Morgan Stanley, Investment Banking and Brokerage Investments
4,649US$40.7k-5.1%no data
0.16%
Chase Leavitt
4,238US$37.1k25.5%no data
0.16%
Northern Trust Global Investments
4,235US$37.1k0%no data
0.16%
Two Sigma Advisers, LP
4,180US$36.6k-15%no data
0.14%
Two Sigma Investments, LP
3,734US$32.7k0%no data
0.14%
Michael Carter
3,702US$32.4k0%no data
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.